Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Li

Bioanalysis

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Bioanalysis|January 22, 2026
Managing the transition: switching bioanalytical laboratories during a clinical trial - a sponsor's perspectiveKetaki Deshpande, Mira Hong, Mark Ware, et al.
Bioanalysis|August 14, 2013
Ask the experts: automation: part IJohn L Allinson, Kenneth E Blick, Lucinda Cohen, et al.
Bioanalysis|November 19, 2010
Automated sample preparation for regulated bioanalysis: an integrated multiple assay extraction platform using robotic liquid handlingJoseph A Tweed, Zhenhua Gu, Hui Xu, et al.
Bioanalysis|February 3, 2026
Mitigation of pre-existing immunogenicity in ADA method developmentJihua Chen, Henry Zhao, Chris Gardner, et al.
Bioanalysis|June 23, 2012
MARS: bringing the automation of small-molecule bioanalytical sample preparations to a new frontierMing Li, Judy Chou, Jing Jing, et al.
Bioanalysis|December 23, 2025
A systematic approach to improve the initial success rates of bioanalytical assay transfers to contract research organizationsMing Li, Jay Ma, Mark Ma, et al.
Bioanalysis|January 25, 2025
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bioanalysis by Multiple Platforms; Super Sensitive ADA/NAb LBA (<u>PART 2A</u> - Recommendations on Advanced Strategies for Biomarkers, IVD/CDx Assays (BAV), Cell Based Assays (CBA), and Ligand-Binding Assays (LBA) <u>PART 2B</u> - Regulatory Agencies' Input on Biomarkers, IVD/CDx, and Biomarker Assay Validation)Nicoletta Bivi, Danielle Graham, Laura Joglekar, et al.
Bioanalysis|June 20, 2024
2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (<u>PART 2</u> - Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies)Olga Kholmanskikh, Yow-Ming Wang, Sarah Hersey, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioanalysis|January 22, 2026
Managing the transition: switching bioanalytical laboratories during a clinical trial - a sponsor's perspectiveKetaki Deshpande, Mira Hong, Mark Ware, et al.
Bioanalysis|August 14, 2013
Ask the experts: automation: part IJohn L Allinson, Kenneth E Blick, Lucinda Cohen, et al.
Bioanalysis|November 19, 2010
Automated sample preparation for regulated bioanalysis: an integrated multiple assay extraction platform using robotic liquid handlingJoseph A Tweed, Zhenhua Gu, Hui Xu, et al.
Bioanalysis|February 3, 2026
Mitigation of pre-existing immunogenicity in ADA method developmentJihua Chen, Henry Zhao, Chris Gardner, et al.
Bioanalysis|June 23, 2012
MARS: bringing the automation of small-molecule bioanalytical sample preparations to a new frontierMing Li, Judy Chou, Jing Jing, et al.
Bioanalysis|December 23, 2025
A systematic approach to improve the initial success rates of bioanalytical assay transfers to contract research organizationsMing Li, Jay Ma, Mark Ma, et al.
Bioanalysis|January 25, 2025
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bioanalysis by Multiple Platforms; Super Sensitive ADA/NAb LBA (<u>PART 2A</u> - Recommendations on Advanced Strategies for Biomarkers, IVD/CDx Assays (BAV), Cell Based Assays (CBA), and Ligand-Binding Assays (LBA) <u>PART 2B</u> - Regulatory Agencies' Input on Biomarkers, IVD/CDx, and Biomarker Assay Validation)Nicoletta Bivi, Danielle Graham, Laura Joglekar, et al.
Bioanalysis|June 20, 2024
2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (<u>PART 2</u> - Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies)Olga Kholmanskikh, Yow-Ming Wang, Sarah Hersey, et al.
Pageof 2